Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
U. Frey (Bern, Switzerland). Complexity in chronic asthma and COPD: implications for risk assessment, disease progression and control. Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium

Member's Comments

No comment yet.

Related content which might interest you: Management of patients with asthma or COPD and cardiovascular disease: risks versus benefits Source: Eur Respir Monogr 2020; 88: 66-81 Year: 2020 Socioeconomic risk factors for COPD and respiratory symptoms in a general population Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 Agreement of severity stages and exacerbations building the new COPD risk groups Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013 The coexistence of asthma and COPD: risk factors, clinical history and lung function trajectories Source: Eur Respir J, 58 (5) 2004656; 10.1183/13993003.04656-2020 Year: 2021 Assessment of a disease management program for patients with asthma or COPD Source: Eur Respir J 2005; 26: Suppl. 49, 19s Year: 2005 Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 The future of disease monitoring and management: the homework for clinical researchers Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Epidemiology of COPD: social burden and trends for the future Source: Annual Congress 2006 - PG13 - COPD: from aetiology to management Year: 2006 The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases Source: International Congress 2014 – Markers Year: 2014 Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 COPD exacerbations: definitions and classifications Source: Eur Respir J 2003; 21: 46S-53S Year: 2003 4–year trajectory of medication adherence amongst severe asthma patients: Risk factors and impact on asthma control Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes Source: Eur Respir J 2003; 21: 30S-35S Year: 2003 The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Physical activity practice reduces risk of admission for a COPD exacerbation in COPD from a prospective population based study Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases Year: 2005 Chronic asthma and the risk of cardiovascular disease Source: Eur Respir Monogr 2020; 88: 82-95 Year: 2020 Subphenotyping COPD: is it relevant for therapeutic intervention and disease outcome? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 How beneficial might be using the Lüscher colour test in the psychological assessment of COPD patients? Source: International Congress 2015 – Best abstracts in COPD management Year: 2015 Chronic obstructive pulmonary disease phenotypes, nutritional status and the risk of falls Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases Year: 2016 Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021